Bright Minds Biosciences Inc (DRUG) returns
Bright Minds Biosciences returns over 5 years
$1,000 invested in Bright Minds Biosciences five years ago was worth $1,544 at the close on October 30, 2026, with dividends reinvested: an average return of 9.1% a year. The same $1,000 in the S&P 500 (SPY) became $1,760.
Total return by period
| Period | Total return | A year, on average | $1,000 became | S&P 500 (SPY) |
|---|---|---|---|---|
| 1 month | +10.4% | — | $1,104 | -0.9% |
| 3 months | -26.3% | — | $736.70 | +2.1% |
| Year to date | -29.5% | — | $704.51 | +11.7% |
| 1 year | +0.9% | — | $1,009 | +12.4% |
| 3 years | +4,034% | +245.8% | $41,338 | +88.5% |
| 5 years | +54.4% | +9.1% | $1,544 | +76.0% |
Bright Minds Biosciences return by calendar year
| Year | DRUG | S&P 500 (SPY) | Difference |
|---|---|---|---|
| 2026 to date | -29.5% | +11.7% | -41.2% |
| 2025 | +116.7% | +17.7% | +98.9% |
| 2024 | +2,419% | +24.9% | +2,394% |
| 2023 | -61.4% | +26.2% | -87.5% |
| 2022 | -76.7% | -18.2% | -58.5% |
Past returns do not predict future returns. Returns are computed from our daily closes, adjusted for splits and with dividends reinvested on their ex-dates; taxes and trading costs are left out.
See also:
No forecast, no recommendation. This page describes Bright Minds Biosciences Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.